CD4 and non-small cell lung carcinoma: In such cases, NSCLC exhibits a non-T cell inflammatory microenvironment with limited infiltration of CD3+, CD4+, and CD8+ T cells, along with low expression of PD-L1 in tumour cells, despite having a moderate to high tumour mutation burden (TMB) [51].